Regeneron Provides Update on Phase 3 Trial of Fianlimab (LAG-3 Inhibitor) Combination in First-Line Unresectable or Metastatic Melanoma
May 15, 2026 20:19 ET | Source: Regeneron Pharmaceuticals, Inc. The trial…
UPDATE Next Generation of Scientific Leaders Awarded More Than $7 Million at the 2026 Regeneron International Science and Engineering Fair
TARRYTOWN, N.Y. and WASHINGTON, May 15, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals,…
NYSE Content Update: Lynn Martin Calls for AI Coordination as U.S. Business Representative in Shanghai
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK,…
NYSE Content Update: Blackstone Digital Infrastructure Debuts for Trade after $1.8 Billion IPO
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK,…
ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal…
NYSE Content Update: Global Medical Response to Go Public After $479 Million IPO
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK,…
UPDATE Proper Hills Launches Ultra-Slim Alloy Magnetic Power Bank for Design-Conscious Consumers
Proper Hills has released an ultra-slim alloy magnetic power bank that delivers…
NYSE Content Update: Disney CEO Josh D’Amaro Rings Bell Ahead of Upfront Event
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK,…
Q1 2026 Update: Tecan on track with low-single-digit local currency growth in Q1; full-year 2026 outlook confirmed
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation…
NYSE Content Update: Eli Lilly to Celebrate 150 Years of Scientific Innovation
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK,…
